Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

3751 - 3760 of 4858 results found

Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Per...

Date
Monday, May 22, 2023 - 4:00 AM
Description
CONCLUSIONS: Monovalent mRNA booster doses provided additional protection against symptomatic SARS-CoV-2 infection during BA.2/BA.2.12.1 and BA.4/BA.5 subvariant circulation, but protection waned over time.

Effects of Mask Reuse on the Oropharyngeal, Skin and Mask Microbiome

Date
Monday, May 22, 2023 - 4:00 AM
Description
CONCLUSIONS: One week of mask re-use increased the number of low-abundance taxa on the face but did not impact the upper respiratory microbiome. Thus, face mask re-use has little impact on the host microbiome, though whether minor changes to the skin

Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Per...

Date
Monday, May 22, 2023 - 4:00 AM
Description
CONCLUSIONS: Monovalent mRNA booster doses provided additional protection against symptomatic SARS-CoV-2 infection during BA.2/BA.2.12.1 and BA.4/BA.5 subvariant circulation, but protection waned over time.

Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Per...

Date
Monday, May 22, 2023 - 4:00 AM
Description
CONCLUSIONS: Monovalent mRNA booster doses provided additional protection against symptomatic SARS-CoV-2 infection during BA.2/BA.2.12.1 and BA.4/BA.5 subvariant circulation, but protection waned over time.

Evolving spike-protein N -glycosylation in SARS-CoV-2 variants

Date
Monday, May 22, 2023 - 4:00 AM
Description
It has been three years since SARS-CoV-2 emerged and the world plunged into a "once in a century" pandemic. Since then, multiple waves of infection have swept through the human population, led by variants that were able to evade any acquired immunity